SUPPLIES

Gene Therapy Medications
Focus on Modern Approaches
Somatic Cell Therapy Medications
Tissue-Engineered Medications
The main focus of JSC Pharmimex is the procurement and wholesale supply of pharmaceuticals, substances, medical products, therapeutic cosmetics, and related goods; pharmaceutical production; and drug registration.

With the approval of the Ministry of Health of the Russian Federation, JSC Pharmimex imports unregistered medicines into Russia that are prescribed for patients with orphan diseases based on vital indications.
The company procures medicines based on direct long-term contracts with manufacturers, ensuring a wide range of products, timely and complete fulfillment of pharmaceutical needs, and completely eliminating the possibility of counterfeit products.

Long-term partnerships with suppliers, joint planning, mutual information exchange, and favorable payment conditions allow JSC Pharmimex to effectively manage its inventory, including forming reserve stock, which is especially critical for scarce medications.
During scheduled audits by international companies, JSC Pharmimex regularly confirms that its compliance system meets international standards. In 2020, the company underwent a compliance audit, after which it became a member of the World Compliance Association.
JSC Pharmimex successfully passes periodic audits for compliance with GDP and ISO requirements, consistently demonstrating high performance in the storage and transportation of pharmaceutical products during these audits.
JSC Pharmimex holds certificates from LLC "Federal Register" confirming compliance with the GOST R ISO 9001-2015 (ISO 9001:2015) standard, as well as a certificate from TUV SUD for compliance with Good Distribution Practice (GDP) requirements.
  • Medications

    JSC Pharmimex supplies pharmaceuticals from leading foreign and Russian companies from its warehouse in Moscow.
    Goods are delivered to any region of Russia by road, rail, and air transport.
    Payment deferrals are available for long-term and reliable partners.
  • Logistics

    Well-established logistics for deliveries across all regions of Russia and the CIS countries, complying with both international and federal requirements for the transportation of special pharmaceutical products (temperature-sensitive, explosive, toxic, etc.). Controlled cold chain adherence throughout the entire storage and delivery process.
  • For Suppliers and Clients

    As the Russian government tightens localization requirements for pharmaceutical production, Pharmimex offers its partners expertise of the highest professional standards.
  • Supplies

    Since 1997, JSC Pharmimex has been one of the key suppliers of medicines for budget procurements.
Medications
JSC Pharmimex supplies pharmaceuticals from leading foreign and Russian companies from its warehouse in Moscow. Goods are delivered to any region of Russia by road, rail, and air transport. Payment deferrals are available for long-term and reliable partners.
1. Priority supply of vital, high-quality medicines to healthcare institutions
2. Provision of essential medicines and medical devices to privileged population groups in Russia
3. Development of wholesale distribution and retail systems in the regions of the Russian Federation
4. Strategic partnership with international and Russian manufacturers of pharmaceutical and biotechnological products
5. Production of biotechnological products
For Suppliers and Clients
Advantages of JSC Pharmimex:

  1. Own facilities, capacities, and resources in key segments of the pharmaceutical market – production, distribution, and retail
  2. Presence of company branches and representative offices in most regions of the Russian Federation
  3. High ethical business standards and adherence to international anti-corruption requirements
  4. Reputation as a reliable partner for medical organizations and patients
In light of the tightening of the Russian government's requirements for localizing pharmaceutical production, Pharmimex offers its partners the following high-level professional competencies:

  1. Registration of pharmaceuticals
  2. Development and participation in programs for product market entry
  3. Logistics services and pharmaceutical distribution
  4. Programs for market and patient needs analysis
  5. Monitoring of pharmaceutical stock and market movement
Logistics
Based on its practical experience with best practices, Pharmimex utilizes modern validated/qualified equipment and specially trained qualified personnel to ensure the transportation and storage of temperature-sensitive pharmaceuticals, maintaining the necessary conditions for their preservation within the "Cold Chain" system.
Well-established logistics for deliveries across all regions of Russia and CIS countries, complying with both international and federal requirements for the transportation of special pharmaceutical products (temperature-sensitive, explosive, toxic, etc.). Controlled cold chain adherence throughout the entire storage and delivery process.
Delivery to regional sites from the central warehouse complex is ensured in the shortest possible time by: road transport, rail transport, air transport, and mixed modes of transport.
2 modern licensed warehouse complexes in Moscow with a total area of over 9,000 m², equipped with all the necessary technical equipment to meet storage condition requirements.
The distribution network with warehouses is located in 17 regions of Russia. 42,000 m² of warehouse space; Over 2,800 m³ of refrigeration units.
The Cold Chain is a continuously operating system of organizational and practical measures that ensures the required temperature conditions for the storage and transportation of pharmaceuticals at all stages, from the manufacturer to the patient.

The main temperature ranges in the Cold Chain are +2…+8°C; -20°C; -60°C. Minimum temperatures can reach as low as -86°C.

The main list of pharmaceuticals in the Cold Chain that the company distributes includes:


Alkeran, Human Albumin, Beriate, Wilate, Vpriv, Ilaris, Immunine, Immunate, Cosentyx, Xolair, Leukeran, Naglazyme, Nuwiq, Octanine, Prothromplex, Resnativ, Replagal, Elaprase, Zolgensma, Brineura, Vimizim, Hemate, and others.

Main Components of the Cold Chain
  • Specially trained personnel ensuring the correct operation of refrigeration equipment, proper storage, and transportation of pharmaceuticals
  • Refrigeration equipment designed for storing and transporting pharmaceuticals under required temperature conditions
  • A control mechanism to monitor compliance with required temperature conditions at all stages of storage and transportation of pharmaceuticals
Our Cold Chain Fully Complies With:
  • International GDP Practice (Good Distribution Practice)
  • Order No. 646n dated August 31, 2016, on the approval of the rules for the proper storage and transportation of pharmaceuticals for medical use
  • SP 3.3.23332-16 "Conditions for the transportation and storage of immunobiological pharmaceutical products"
To Ensure the Cold Chain, the Company Has:
  • Qualified refrigeration rooms equipped with a validated temperature and humidity monitoring system that allows for controlling the required temperature conditions, notifying responsible personnel of any changes, recording and storing data on storage conditions, and providing this data upon request.
  • The refrigeration chambers at Pharmimex's warehouses exceed 2,800 m³ in volume.
  • Qualified thermal containers equipped with special temperature indicators for transportation.
  • Validated vehicles equipped with a monitoring system that allows for controlling the required temperature conditions, notifying the driver of changes, recording and storing data on the transportation conditions, and providing this data to the recipient.
  • Capability for delivering pharmaceuticals across Russia by road and air transport.
State Procurement
Since 1997, JSC Pharmimex has been one of the key suppliers of medicines for budget programs.
14 High-Cost Nosologies

  • 20% share in supplies for the High-Cost Nosologies Program
  • Supplies of medications for the treatment of hemophilia and Gaucher disease
Budget Programs

Treatment of oncological diseases
Supplies of medications for the treatment of:
  • Malignant melanoma
  • Breast cancer
  • Kidney cancer
  • Lung cancer and others
Treatment of Orphan Diseases

  • JSC Pharmimex supplies medications for the treatment of 14 out of 24 life-threatening and chronic progressive rare (orphan) diseases that lead to reduced life expectancy or disability.
  • Share in supplies for regional programs – about 68%